When considering the later time points at days 60, 90, and 120, the trend of percent ALC change in the CD49d+ CLL group was again similar among the three different cohorts (Fig. 4 B, bottom). This evidence concerns the gene ITGA4 and B-cell chronic lymphocytic leukemia.